A description is not currently available for this report.
Report Content Chapter 1 Methodology & Scope 1.1 Market scope & definitions 1.2 Research design 1.2.1 Research approach 1.2.2 Data collection methods 1.3 Base estimates & calculations 1.3.1 Base year calculation 1.3.2 Key trends for market estimation 1.4 Forecast model 1.5 Primary research and validation 1.5.1 Primary sources 1.5.2 Data mining sources Chapter 2 Executive Summary 2.1 Industry 360-degree synopsis Chapter 3 Industry Insights 3.1 Industry ecosystem analysis 3.2 Industry impact forces 3.2.1 Growth drivers 3.2.1.1 Globalization of clinical trials 3.2.1.2 Increasing prevalence of genetic and chronic diseases 3.2.1.3 Growing advancements in gene therapy technologies 3.2.1.4 Expanded applications in oncology and rare diseases 3.2.2 Industry pitfalls & challenges 3.2.2.1 Stringent regulatory challenges 3.3 Growth potential analysis 3.4 Regulatory landscape 3.5 PESTEL analysis Chapter 4 Competitive Landscape, 2023 4.1 Introduction 4.2 Company matrix analysis 4.3 Competitive analysis of major market players 4.4 Competitive positioning matrix 4.5 Strategy dashboard Chapter 5 Market Estimates and Forecast, By Services, 2021 - 2032 ($ Mn) 5.1 Key trends 5.2 Clinical trial design & planning 5.3 Supply & logistics services 5.4 Regulatory services 5.5 Data management & biostatistics 5.6 Site management & monitoring 5.7 Other services Chapter 6 Market Estimates and Forecast, By Service, 2021 - 2032 ($ Mn) 6.1 Key trends 6.2 Oncology 6.3 Hematology 6.4 Endocrine/ metabolic disorders 6.5 Musculoskeletal 6.6 Cardiovascular diseases (CVD) 6.7 Neurology disorders 6.8 Infectious disease 6.9 Ophthalmology 6.10 Immunology 6.11 Other therapeutic areas Chapter 7 Market Estimates and Forecast, By End-user, 2021 - 2032 ($ Mn) 7.1 Key trends 7.2 Pharmaceutical & biotechnology companies 7.3 Contract research organizations (CROs) 7.4 Academic and research institutes 7.5 Other end-users Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn) 8.1 Key trends 8.2 North America 8.2.1 U.S. 8.2.2 Canada 8.3 Europe 8.3.1 Germany 8.3.2 UK 8.3.3 France 8.3.4 Spain 8.3.5 Italy 8.3.6 Netherlands 8.3.7 Rest of Europe 8.4 Asia Pacific 8.4.1 Japan 8.4.2 China 8.4.3 India 8.4.4 Australia 8.4.5 South Korea 8.4.6 Rest of Asia Pacific 8.5 Latin America 8.5.1 Brazil 8.5.2 Mexico 8.5.3 Rest of Latin America 8.6 Middle East and Africa 8.6.1 Saudi Arabia 8.6.2 South Africa 8.6.3 UAE 8.6.4 Rest of Middle East and Africa Chapter 9 Company Profiles 9.1 Almac Group 9.2 Catalent Biologics 9.3 Charles River Laboratories International, Inc. 9.4 ICON plc 9.5 IQVIA Biotech 9.6 Labcorp Drug Development 9.7 Medpace Holdings, Inc. 9.8 Novotech 9.9 Parexel International (MA) Corporation 9.10 Precision Medicine Group LLC 9.11 Sharp Services, LLC 9.12 Thermo Fisher Scientific Inc. 9.13 Worldwide Clinical Trials
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook